1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Diabetes Care Devices Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Diabetes Care Devices Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase in diabetes prevalence
- 5.1.2 Growth in demand for monitoring and management devices
5.2 Market Opportunities
- 5.2.1 Expansion in emerging markets
- 5.2.2 Growth in digital health solutions
5.3 Future Trends
- 5.3.1 Increased adoption of glucose monitoring systems
- 5.3.2 Integration with AI for diabetes management
5.4 Impact of Drivers and Restraints
6. Europe Diabetes Care Devices Market Regional Analysis
6.1 Europe Diabetes Care Devices Market Overview
6.2 Europe Diabetes Care Devices Market Revenue 2020-2028 (US$ Million)
6.3 Europe Diabetes Care Devices Market Forecast Analysis
7. Europe Diabetes Care Devices Market Analysis – by Type
7.1 Glucose Monitoring Devices and Insulin Delivery Devices
- 7.1.1 Overview
- 7.1.2 Glucose Monitoring Devices and Insulin Delivery Devices: Europe Diabetes Care Devices Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Diabetes Care Devices Market Analysis – by End User
8.1 Homecare and Hospitals & Clinics
- 8.1.1 Overview
- 8.1.2 Homecare and Hospitals & Clinics : Europe Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Diabetes Care Devices Market – Europe Analysis
9.1 Europe
- 9.1.1 Europe Diabetes Care Devices Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.1.1.1 Europe Diabetes Care Devices Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 UK:
Europe Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.1.1 UK: Europe Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.1.2 UK: Europe Diabetes Care Devices Market Breakdown, by End User
- 9.1.1.2 Germany:
Europe Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.2.1 Germany: Europe Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.2.2 Germany: Europe Diabetes Care Devices Market Breakdown, by End User
- 9.1.1.3 France:
Europe Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.3.1 France: Europe Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.3.2 France: Europe Diabetes Care Devices Market Breakdown, by End User
- 9.1.1.4 Russia:
Europe Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.4.1 Russia: Europe Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.4.2 Russia: Europe Diabetes Care Devices Market Breakdown, by End User
- 9.1.1.5 Italy:
Europe Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.5.1 Italy: Europe Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.5.2 Italy: Europe Diabetes Care Devices Market Breakdown, by End User
- 9.1.1.6 Rest of Europe:
Europe Diabetes Care Devices Market – Revenue and Forecast to 2028 (US$ Million)
- 9.1.1.6.1 Rest of Europe: Europe Diabetes Care Devices Market Breakdown, by Type
- 9.1.1.6.2 Rest of Europe: Europe Diabetes Care Devices Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Europe Diabetes Care Devices Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 B. Braun Melsungen AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 BD
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Dexcom, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Eli Lilly and Company.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 F. Hoffmann-La Roche Ltd.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Insulet Corporation
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medtronic
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Novo Nordisk A/S
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Tandem Diabetes Care Inc.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Terumo Corporation
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights